Drug Trial Radar · NCT03818321
Urinary Track Infection Prevention After Urogynecological Surgery
Last checked: Nov 19, 2026Latest source record: Nov 14, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
185
Actual
Start
Jun 17, 2019
Primary completion
Jul 1, 2021
Study completion Jul 1, 2021
Sponsor
- Lead sponsor
- TriHealth Inc.Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 28, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is randomized double-blinded placebo-controlled trial to access oral Methenamine Hippurate (MH) in combination with cranberry capsules is superior to cranberry capsules alone in prevention of UTI in patients with transient post-operative urinary retention requiring a Foley catheter after pelvic reconstructive surgery.
Conditions
- Urinary Tract Infections
- Urinary Retention Postoperative
- Pelvic Organ Prolapse
Interventions
Methenamine Hippurate 1 g tabletDrug
Methenamine Hippurate (study drug) is an FDA approved medication in the prevention of UTI. Methenamine Hippurate 1g contains Hippuric acid salt of Methenamine (hexamethylene tetramine), Magnesium Stearate, Povidone, Saccharin Sodium, FD\&C Yellow No. 5 (tartrazine) (www.iodine.com/drug/hiprex/fda-package-insert).
Placebo tabletDrug
Placebo is a tablet that will be provided to you that looks like the study drug but does not contain any medication. These pills are comprised of gelatin and minimal amounts of lactose powder. The pills are designed to have no effect on the patient.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Urinary Track Infection (UTI)Time frame: From surgery to one week post-op visit, approximately 1 week post surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Cincinnati Urogynecology Associates
Cincinnati, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.